Genome-wide association study of treatment refractory schizophrenia in han Chinese

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Liou, Ying Jay ^a,b   Wang, Hui Hung ^c   Lee, Ming Ta Michael ^c,d   Wang, Sheng Chang ^e   Chiang, Hung Lun ^b,c   Chen, Cheng Chung ^f   Lin, Ching Hua ^f   Chung, Ming Shun ^g   Kuo, Chien Cheng ^g   Liao, Ding Lieh ^h   Wu, Ching Kuan ⁱ   Liu, Chih Min ^j   Liu, Yu Li ^e   Hwu, Hai Gwo ^j,k   Lai, I Ching ^l   Tsai, Shih Jen ^a,b   Chen, Chia Hsiang ^e   Liu, Hui Fen ^c   Chou, Yi Chun ^c   Chen, Chien Hsiun ^c,d   Chen, Yuan Tsong ^c,m   Hong, Chen Jee ^a,b   Wu, Jer Yuarn ^c,d   more..

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^f Kaohsiung Kai Suan Psychiatric Hospital   (Taiwan)

^g Jianan Mental Hospital   (Taiwan)

^h Bali Psychiatric Center   (Taiwan)

ⁱ Tsyr Huey Mental Hospital   (Taiwan)

^j NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^k NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^l YULI VETERANS HOSPITAL   (Taiwan)

^m DUKE UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; CHLORPROMAZINE; CLOZAPINE; OLANZAPINE; QUETIAPINE; RISPERIDONE; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; ZIPRASIDONE; ZOTEPINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NFKB1 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE; GENE ACTIVITY; GENE FUNCTION; GENE LOCATION; GENE LOCUS; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; NFKB1 GENE; POPULATION RESEARCH; PROMOTER REGION; RIPK4 GENE; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SLAMF1 GENE; TREATMENT REFRACTORY SCHIZOPHRENIA; TREATMENT RESPONSE; AGED; ASIAN; CELL LINE; GENE LINKAGE DISEQUILIBRIUM; GENETICS; METABOLISM; MIDDLE AGED; TAIWAN;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CELL LINE; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; NF-KAPPA B P50 SUBUNIT; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; TAIWAN;

EID: 84858982485     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033598     Document Type: Article

References (64)

1. Saha S, Chant D, Welham J, McGrath J, (2005) A systematic review of the prevalence of schizophrenia. PLoS Med 2: e141.
2. Chien IC, Chou YJ, Lin CH, Bih SH, Chou P, et al. (2004) Prevalence and incidence of schizophrenia among national health insurance enrollees in Taiwan, 1996-2001. Psychiatry Clin Neurosci 58: 611-618.
3. Hyman SE, (2008) A glimmer of light for neuropsychiatric disorders. Nature 455: 890-893.
4. Gottesman II, (1991) Schizophrenia genesis: the origns of madness New York Freeman.
5. Cardno AG, Gottesman II, (2000) Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am J Med Genet 97: 12-17.
6. Shaikh S, Collier D, Arranz M, Ball D, Gill M, et al. (1994) DRD2 Ser311/Cys311 polymorphism in schizophrenia. Lancet 343: 1045-1046.
7. Inayama Y, Yoneda H, Sakai T, Ishida T, Nonomura Y, et al. (1996) Positive association between a DNA sequence variant in the serotonin 2A receptor gene and schizophrenia. Am J Med Genet 67: 103-105.
8. Freedman R, Coon H, Myles-Worsley M, Orr-Urtreger A, Olincy A, et al. (1997) Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci U S A 94: 587-592.
9. Duan J, Martinez M, Sanders AR, Hou C, Saitou N, et al. (2004) Polymorphisms in the trace amine receptor 4 (TRAR4) gene on chromosome 6q23.2 are associated with susceptibility to schizophrenia. Am J Hum Genet 75: 624-638.
10. de Chaldee M, Laurent C, Thibaut F, Martinez M, Samolyk D, et al. (1999) Linkage disequilibrium on the COMT gene in French schizophrenics and controls. Am J Med Genet 88: 452-457.
11. Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L, Palicio M, et al. (2002) Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci U S A 99: 13675-13680.
12. Hennah W, Varilo T, Kestila M, Paunio T, Arajarvi R, et al. (2003) Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects. Hum Mol Genet 12: 3151-3159.
13. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, et al. (2002) Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 71: 877-892.
14. Chowdari KV, Mirnics K, Semwal P, Wood J, Lawrence E, et al. (2002) Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet 11: 1373-1380.
15. Gerber DJ, Hall D, Miyakawa T, Demars S, Gogos JA, et al. (2003) Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit. Proc Natl Acad Sci U S A 100: 8993-8998.
16. Crow TJ, (2007) How and why genetic linkage has not solved the problem of psychosis: review and hypothesis. Am J Psychiatry 164: 13-21.
17. Sanders AR, Duan J, Levinson DF, Shi J, He D, et al. (2008) No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am J Psychiatry 165: 497-506.
18. O'Donovan MC, Craddock N, Norton N, Williams H, Peirce T, et al. (2008) Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 40: 1053-1055.
19. Riley B, Thiselton D, Maher BS, Bigdeli T, Wormley B, et al. (2009) Replication of association between schizophrenia and ZNF804A in the Irish Case-Control Study of Schizophrenia sample. Mol Psychiatry 15: 29-37.
20. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, et al. (2009) Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460: 753-757.
21. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, et al. (2009) Common variants conferring risk of schizophrenia. Nature 460: 744-747.
22. Athanasiu L, Mattingsdal M, Kahler AK, Brown A, Gustafsson O, et al. (2010) Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort. J Psychiatr Res 44: 748-753.
23. Lencz T, Morgan TV, Athanasiou M, Dain B, Reed CR, et al. (2007) Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia. Mol Psychiatry 12: 572-580.
24. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, et al. (2009) Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460: 748-752.
25. Mah S, Nelson MR, Delisi LE, Reneland RH, Markward N, et al. (2006) Identification of the semaphorin receptor PLXNA2 as a candidate for susceptibility to schizophrenia. Mol Psychiatry 11: 471-478.
26. Shifman S, Johannesson M, Bronstein M, Chen SX, Collier DA, et al. (2008) Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genet 4: e28.
27. Koga M, Ishiguro H, Yazaki S, Horiuchi Y, Arai M, et al. (2009) Involvement of SMARCA2/BRM in the SWI/SNF chromatin-remodeling complex in schizophrenia. Hum Mol Genet 18: 2483-2494.
28. Conley RR, Kelly DL, (2001) Management of treatment resistance in schizophrenia. Biol Psychiatry 50: 898-911.
29. Elkis H, (2007) Treatment-resistant schizophrenia. Psychiatr Clin North Am 30: 511-533.
30. van Kammen DP, Schooler N, (1990) Are biochemical markers for treatment-resistant schizophrenia state dependent or traits? Clin Neuropharmacol 13 (Suppl 1): S16-28.
31. Bilder RM, Wu H, Chakos MH, Bogerts B, Pollack S, et al. (1994) Cerebral morphometry and clozapine treatment in schizophrenia. J Clin Psychiatry 55 (Suppl B): 53-56.
32. Stern RG, Kahn RS, Davidson M, (1993) Predictors of response to neuroleptic treatment in schizophrenia. Psychiatr Clin North Am 16: 313-338.
33. Lee M, Jayathilake K, Dai J, Meltzer H, (2010) Decreased plasma tryptophan and tryptophan/large neutral amino acid ratio in patients with neuroleptic-resistant schizophrenia: Relationship to plasma cortisol concentration. Psychiatry Res.
34. Karban AS, Okazaki T, Panhuysen CI, Gallegos T, Potter JJ, et al. (2004) Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet 13: 35-45.
35. Lin L, DeMartino GN, Greene WC, (1998) Cotranslational biogenesis of NF-kappaB p50 by the 26S proteasome. Cell 92: 819-828.
36. Rice NR, MacKichan ML, Israel A, (1992) The precursor of NF-kappa B p50 has I kappa B-like functions. Cell 71: 243-253.
37. Liou HC, Nolan GP, Ghosh S, Fujita T, Baltimore D, (1992) The NF-kappa B p50 precursor, p105, contains an internal I kappa B-like inhibitor that preferentially inhibits p50. Embo J 11: 3003-3009.
38. Shishodia S, Aggarwal BB, (2004) Nuclear factor-kappaB: a friend or a foe in cancer? Biochem Pharmacol 68: 1071-1080.
39. Zhong H, May MJ, Jimi E, Ghosh S, (2002) The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell 9: 625-636.
40. Chen F, Castranova V, Shi X, Demers LM, (1999) New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. Clin Chem 45: 7-17.
41. Tatsuo H, Ono N, Tanaka K, Yanagi Y, (2000) SLAM (CDw150) is a cellular receptor for measles virus. Nature 406: 893-897.
42. Berger SB, Romero X, Ma C, Wang G, Faubion WA, et al. (2010) SLAM is a microbial sensor that regulates bacterial phagosome functions in macrophages. Nature immunology 11: 920-927.
43. Griewank K, Borowski C, Rietdijk S, Wang N, Julien A, et al. (2007) Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development. Immunity 27: 751-762.
44. Quiroga MF, Martinez GJ, Pasquinelli V, Costas MA, Bracco MM, et al. (2004) Activation of signaling lymphocytic activation molecule triggers a signaling cascade that enhances Th1 responses in human intracellular infection. Journal of immunology 173: 4120-4129.
45. Cannons JL, Yu LJ, Hill B, Mijares LA, Dombroski D, et al. (2004) SAP regulates T(H)2 differentiation and PKC-theta-mediated activation of NF-kappaB1. Immunity 21: 693-706.
46. Chung B, Aoukaty A, Dutz J, Terhorst C, Tan R, (2005) Signaling lymphocytic activation molecule-associated protein controls NKT cell functions. J Immunol 174: 3153-3157.
47. Bhr C, Rohwer A, Stempka L, Rincke G, Marks F, et al. (2000) DIK, a novel protein kinase that interacts with protein kinase Cdelta. Cloning, characterization, and gene analysis. J Biol Chem 275: 36350-36357.
48. Meylan E, Tschopp J, (2005) The RIP kinases: crucial integrators of cellular stress. Trends Biochem Sci 30: 151-159.
49. Hashimoto R, Ohi K, Yasuda Y, Fukumoto M, Yamamori H, et al. (2011) Variants of the RELA gene are associated with schizophrenia and their startle responses. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology 36: 1921-1931.
50. Barnes PJ, Karin M, (1997) Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336: 1066-1071.
51. Katila H, Appelberg B, Hurme M, Rimon R, (1994) Plasma levels of interleukin-1 beta and interleukin-6 in schizophrenia, other psychoses, and affective disorders. Schizophr Res 12: 29-34.
52. Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, et al. (2008) Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 63: 801-808.
53. Song XQ, Lv LX, Li WQ, Hao YH, Zhao JP, (2009) The interaction of nuclear factor-kappa B and cytokines is associated with schizophrenia. Biol Psychiatry 65: 481-488.
54. Lin A, Kenis G, Bignotti S, Tura GJ, De Jong R, et al. (1998) The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6. Schizophr Res 32: 9-15.
55. Maes M, Bocchio Chiavetto L, Bignotti S, Battisa Tura G, Pioli R, et al. (2000) Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics. Eur Neuropsychopharmacol 10: 119-124.
56. Maes M, Bocchio Chiavetto L, Bignotti S, Battisa Tura GJ, Pioli R, et al. (2002) Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor. Schizophr Res 54: 281-291.
57. Ten RM, Paya CV, Israel N, Le Bail O, Mattei MG, et al. (1992) The characterization of the promoter of the gene encoding the p50 subunit of NF-kappa B indicates that it participates in its own regulation. Embo J 11: 195-203.
58. Ueda S, Fujimoto S, Hiramoto K, Negishi M, Katoh H, (2008) Dock4 regulates dendritic development in hippocampal neurons. J Neurosci Res 86: 3052-3061.
59. Alkelai A, Lupoli S, Greenbaum L, Kohn Y, Kanyas-Sarner K, et al. (2011) DOCK4 and CEACAM21 as novel schizophrenia candidate genes in the Jewish population. The international journal of neuropsychopharmacology/official scientific journal of the Collegium Internationale Neuropsychopharmacologicum pp. 1-11.
60. Kohlrausch FB, Gama CS, Lobato MI, Belmonte-de-Abreu P, Callegari-Jacques SM, et al. (2008) Naturalistic pharmacogenetic study of treatment resistance to typical neuroleptics in European-Brazilian schizophrenics. Pharmacogenet Genomics 18: 599-609.
61. Joober R, Benkelfat C, Brisebois K, Toulouse A, Turecki G, et al. (1999) T102C polymorphism in the 5HT2A gene and schizophrenia: relation to phenotype and drug response variability. J Psychiatry Neurosci 24: 141-146.
62. Ji X, Takahashi N, Saito S, Ishihara R, Maeno N, et al. (2008) Relationship between three serotonin receptor subtypes (HTR3A, HTR2A and HTR4) and treatment-resistant schizophrenia in the Japanese population. Neurosci Lett 435: 95-98.
63. Pan WH, Fann CS, Wu JY, Hung YT, Ho MS, et al. (2006) Han Chinese cell and genome bank in Taiwan: purpose, design and ethical considerations. Hum Hered 61: 27-30.
64. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA, (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70: 425-434.